Intriguingly, one recent study identified that one single immune-related gene, CXCL11, could be an effective independent prognostic biomarker for colon cancer patients and upregulation of CXCL11 expression was correlated with a PD-L1 high expression level (31). The gene discussed is CXCL11; the disease is malignant colon neoplasm.